A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues
- PMID: 9600316
- DOI: 10.1046/j.1365-3083.1998.00311.x
A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues
Abstract
Amyloidosis is characterized by deposition of protein fibrils in various tissues. The wide variety of sequences of both amyloidogenic and non-amyloidogenic immunoglobulin light chains makes them a unique tool for addressing the importance of primary structure in the formation of insoluble fibrils. In this study, we have determined the primary structure of the kappa I immunoglobulin light chain from both the urinary Bence Jones protein and the deposited amyloid fibrils of a patient (MH) with primary amyloidosis. The sequence identity of urinary-excreted and tissue-deposited light chains excluded biclonality and somatic mutations and confirmed that the light chain existed in both a soluble and an insoluble form. Several residues have been previously reported to be significantly associated with amyloidogenic kappa chains. Many of these were found in the MH sequence, including Asp31, Asn45, Phe49, Gln55, His70, Asn/Gly93 and ProN/Val96, thereby supporting their potential role in fibrillogenesis. In addition, Asn20 and Pro60 of protein MH replaced the normally conserved Thr20 and Ser60. Asn20 was glycosylated in both the Bence Jones and the amyloid fibril protein MH. Cumulative effects of amyloid-associated residues and glycosylation might have rendered the immunoglobulin light chain MH prone to fibril formation.
Similar articles
-
Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein.Scand J Immunol. 1998 Jul;48(1):92-8. doi: 10.1046/j.1365-3083.1998.00352.x. Scand J Immunol. 1998. PMID: 9714416
-
Structural analysis of the amyloidogenic kappa Bence Jones protein (FUR).Amyloid. 1999 Jun;6(2):77-88. doi: 10.3109/13506129909007307. Amyloid. 1999. PMID: 10439113
-
Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.J Mol Recognit. 2000 Jul-Aug;13(4):198-212. doi: 10.1002/1099-1352(200007/08)13:4<198::AID-JMR499>3.0.CO;2-D. J Mol Recognit. 2000. PMID: 10931557
-
Current concepts of the formation and composition of amyloid.Ann Clin Lab Sci. 1975 Jul-Aug;5(4):257-63. Ann Clin Lab Sci. 1975. PMID: 808999 Review.
-
ALkappa(I) (UNK) - primary structure of an AL-amyloid protein presenting an organ-limited subcutaneous nodular amyloid syndrome of long duration. Case report and review.Amyloid. 2010 Mar;17(1):10-23. doi: 10.3109/13506121003619328. Amyloid. 2010. PMID: 20146644 Review.
Cited by
-
Abnormal N-glycosylation of the immunoglobulin G kappa chain in a multiple myeloma patient with crystalglobulinemia: case report.Int J Hematol. 2007 Apr;85(3):203-6. doi: 10.1532/IJH97.06074. Int J Hematol. 2007. PMID: 17483055
-
Heterogeneity in primary structure, post-translational modifications, and germline gene usage of nine full-length amyloidogenic kappa1 immunoglobulin light chains.Biochemistry. 2007 Dec 11;46(49):14259-71. doi: 10.1021/bi7013773. Epub 2007 Nov 16. Biochemistry. 2007. PMID: 18004879 Free PMC article.
-
Role of the mechanisms for antibody repertoire diversification in monoclonal light chain deposition disorders: when a friend becomes foe.Front Immunol. 2023 Jul 13;14:1203425. doi: 10.3389/fimmu.2023.1203425. eCollection 2023. Front Immunol. 2023. PMID: 37520549 Free PMC article. Review.
-
Light chain amyloidosis - current findings and future prospects.Curr Protein Pept Sci. 2009 Oct;10(5):500-508. doi: 10.2174/138920309789351949. Curr Protein Pept Sci. 2009. PMID: 19538145 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical